Pharmacological Agents in the Clinic: Trial and Error
Journal Title: Heart Research – Open Journal - Year 2015, Vol 2, Issue 4
Abstract
Following an explosion of molecular and cellular research in the last 50 years, the study of specific molecular targets in the context of heart failure has generated much excitement. With the incidence of heart failure rising worldwide, new pharmacological agents are eagerly anticipated as a key tool with the potential for significant impact. In this regard, the results of the keenly awaited Does Cyclosporine Improve Clinical Outcome in ST Elevation Myocardial Infarction Patients (CIRCUS) trial have just been made available. Despite a substantial programme of supporting experimental and preclinical evidence however, the results have proved negative. This is of great disappointment to the clinical and scientific community. Here, this is discussed in the context of previous studies and future directions explored.
Authors and Affiliations
Lorna R. Fiedler
Keywords
Related Articles
- EP ID EP556937
- DOI 10.17140/HROJ-2-122
- Views 121
- Downloads 0
Diagnostic Value of Coronary CT Angiography With Use of Left Coronary Bifurcation Angle in Coronary Artery Disease
Background: Atherosclerosis generally occurs in the blood vessels with angulation or curvature, however, association between coronary bifurcation angle and coronary artery disease needs to be further clarified when compa...
Anthracycline Cardiotoxicity: Strategies for Prevention and Intervention
The cardiotoxic effects of anthracycline compounds, used extensively to treat malignancies such as breast cancer and lymphoma, are well known.1,2 However, despite efforts towards cardioprotective strategies and early det...
Small Ventricular Septal Defect Considered not Requiring Surgical Closure: The Frequency of Developing Complications in Our Center
Objectives: The study was conducted to check the frequency of development of complication in the patients with small Ventricular Septal Defects (VSDs) considered not requiring surgical closure during childhood. Methods:...
Dimethyl Sulfoxide Reduces Microvascular Obstruction and Intramyocardial Hemorrhage in a Porcine Ischemia-Reperfusion Model
Background: Microvascular obstruction (MVO) and Intramyocardial hemorrhage (IMH) are associated with myocardial reperfusion injury and recognized as predictors of adverse left ventricular remodeling in acute myocardial i...
Saroglitazar: A New Drug to Treat Diabetic Hypertriglyceridemia
Dyslipidemia alone has been considered as one of the major modifiable risk factor for cardiovascular diseases (CVD) accounting for 50% of the 1st myocardial infarction (MI) cases worldwide.1 A recent epidemiological sur...